The University of Chicago Header Logo

Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease.

Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease. Curr Gastroenterol Rep. 2007 Dec; 9(6):487-8.

View in: PubMed